TransMedics Group, Inc. (TMDX) NASDAQ

117.38

+2.2(+1.91%)

Updated at August 27 04:00PM

Currency In USD

TransMedics Group, Inc.

Address

200 Minuteman Road

Andover, MA 01810

United States of America

Phone

978 552 0900

Sector

Healthcare

Industry

Medical - Devices

Employees

728

First IPO Date

May 02, 2019

Key Executives

NameTitlePayYear Born
Dr. Waleed H. Hassanein M.D.Founder, President, Chief Executive Officer & Director2.1M1968
Mr. Gerardo HernandezChief Financial Officer & Treasurer214,6191971
Ms. Miriam C. Provost Ph.D.Vice President of Global Regulatory Affairs535,9301961
Mr. Anil RanganathSenior Vice President, General Counsel & Corporate Secretary594,2501981
Mr. Nicholas CorcoranSenior Vice President of Supply Chain & Operations826,9041983
Dr. Tamer I. Khayal M.D.Chief Commercial Officer1.07M1969

Description

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for extracorporeal perfusion and preservation of donor hearts; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.